Tekmira Provides Periodic Update on TKM-Ebola Program

News   Oct 31, 2014

 
Tekmira Provides Periodic Update on TKM-Ebola Program
 
 
 

RELATED ARTICLES

First-in-Human Trial Evaluating Ebola Treatment Begins

News

A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun. The Phase 1 clinical trial is examining the safety and tolerability of a single monoclonal antibody called mAb114

READ MORE

Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT Biotech

News

Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.

READ MORE

SCRaMbLE Speeds Up Yeast Evolution

News

Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE